Author:
Pathan Nazima,Woolfall Kerry,Popa Mariana,de la Fuente Gema Milla,Ferrando-Vivas Paloma,Brown Alanna,Gouliouris Theodore,Tume Lyvonne N.,Shulman Robert,Cuthbertson Brian H.,Sale Isobel,Feltbower Richard G.,Myburgh John,Pappachan John,Harrison David,Mouncey Paul,Rowan Kathryn,Fulham Charlotte,James Melanie,Beadon Kirsten,Postlethwaite Cat,Pond Jenny,Hargadon-Lowe Antonia,Cassidy Jane,Robbins Ceri,Milner Phil,Dwarakanathan Buvana,De Queiroz Joana Gomes,Daubney Esther,White Deborah,Davis Peter,Dodge Laura,Moody Francesca,
Abstract
AbstractHealthcare-associated infections (HCAIs) are a major cause of morbidity and mortality in critically ill children. Data from adult studies suggest Selective Decontamination of the Digestive tract (SDD) may reduce the incidence of HCAIs and improve survival. There are no data from randomised clinical trials in the paediatric setting. An open label, parallel group pilot cRCT and mixed-methods perspectives study was conducted in six paediatric intensive care units (PICUs) in England. Participants were children (> 37 weeks corrected gestational age, up to 16 years) requiring mechanical ventilation expected to last for at least 48 h. Sites undertook standard care for a period of 9 weeks and were randomised into 3 sites which continued standard care and 3 where SDD was incorporated into infection control practice for eligible children. Interviews and focus groups were conducted for parents and staff working in PICU. 434 children fulfilled eligibility criteria, of whom 368 (85%) were enrolled. This included 207 in the baseline phase (Period One) and 161 in the intervention period (Period Two). In sites delivering SDD, the majority (98%) of children received at least one dose of SDD and of these, 68% commenced within the first 6 h. Whilst admission swabs were collected in 91% of enrolled children, consent for the collection of additional swabs was low (44%). Recruited children were representative of the wider PICU population. Overall, 3.6 children/site/week were recruited compared with the potential recruitment rate for a definitive cRCT of 3 children/site/week, based on data from all UK PICUs. Parents (n = 65) and staff (n = 44) were supportive of the aims of the study, suggesting adaptations for a larger definitive trial including formulation and administration of SDD paste, approaches to consent and ecology monitoring. Stakeholders identified preferred clinical outcomes, focusing on complications of critical illness and quality-of-life. A definitive cRCT in SDD to prevent HCAIs in critically ill children is feasible but should include adaptations to ecology monitoring along with the dosing schedule and packaging into a paediatric specific format. A definitive study is supported by the findings with adaptations to ecology monitoring and SDD administration.Trial Registration: ISRCTN40310490 Registered 30/10/2020.
Funder
NIHR Cambridge Biomedical Research Centre
University of Cambridge
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Patrick, S. W. et al. Health care-associated infections among critically ill children in the US, 2007–2012. Pediatrics 134(4), 705–712 (2014).
2. Field-Ridley, A., Dharmar, M., Steinhorn, D., McDonald, C. & Marcin, J. P. ICU-acquired weakness is associated with differences in clinical outcomes in critically Ill children. Pediatr. Crit. Care Med. J. Soc. Crit. Care Med. World Fed. Pediatr. Intens. Crit. Care Soc. 17(1), 53–57 (2015).
3. Choong, K. et al. Functional recovery following critical illness in children: the “wee-cover” pilot study. Pediatr. Crit. Care Med. J. Soc. Crit. Care Med. World Fed. Pediatr. Intens. Crit. Care Soc. 16(4), 310–318 (2015).
4. Heyland, D. K., Cook, D. J., Griffith, L., Keenan, S. P. & Brun-Buisson, C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am. J. Respir. Crit. Care Med. 159(41), 1249–1256 (1999).
5. Bekaert, M. et al. Attributable mortality of ventilator-associated pneumonia: A reappraisal using causal analysis. Am. J. Respir. Crit. Care Med. 184(10), 1133–1139 (2011).